GAMBIRASI, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 133
AS - Asia 118
EU - Europa 60
SA - Sud America 13
AF - Africa 4
OC - Oceania 1
Totale 329
Nazione #
US - Stati Uniti d'America 129
SG - Singapore 43
IT - Italia 25
CN - Cina 21
VN - Vietnam 15
KR - Corea 14
DE - Germania 8
FI - Finlandia 8
BR - Brasile 7
HK - Hong Kong 5
IN - India 5
RU - Federazione Russa 5
FR - Francia 4
MA - Marocco 3
PL - Polonia 3
TR - Turchia 3
TW - Taiwan 3
AR - Argentina 2
AT - Austria 2
EC - Ecuador 2
JO - Giordania 2
MX - Messico 2
MY - Malesia 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CA - Canada 1
CH - Svizzera 1
CL - Cile 1
GB - Regno Unito 1
HN - Honduras 1
JP - Giappone 1
NP - Nepal 1
PY - Paraguay 1
SA - Arabia Saudita 1
Totale 329
Città #
Dallas 69
Singapore 29
San Jose 18
Seoul 12
Ashburn 9
Council Bluffs 9
Hefei 9
Hanoi 7
Ho Chi Minh City 5
Helsinki 4
Hong Kong 4
Munich 4
Bari 3
Beijing 3
Casablanca 3
Chennai 3
Chicago 3
Frankfurt am Main 3
Lauterbourg 3
Trieste 3
Zgierz 3
Amman 2
Ankara 2
Florence 2
Kuala Lumpur 2
Milan 2
Moscow 2
Orem 2
Padova 2
Palermo 2
Salzburg 2
San Giorgio di Nogaro 2
Santa Clara 2
Turku 2
Winston-Salem 2
Asunción 1
Atlanta 1
Baku 1
Barberton 1
Boardman 1
Bologna 1
Buffalo 1
Buraidah 1
Cabo Frio 1
Columbus 1
Crevalcore 1
Da Nang 1
Duque de Caxias 1
Florianópolis 1
Fribourg 1
Gatchina 1
Glassboro 1
Guangzhou 1
Gyeongsan-si 1
Hamburg 1
Hangzhou 1
Incheon 1
Irecê 1
Istrana 1
Kathmandu 1
London 1
Los Angeles 1
Luanda 1
Ludhiana 1
Mexico City 1
Minsk 1
Morelia 1
New Taipei City 1
New York 1
Novokuznetsk 1
Omaha 1
Ottawa 1
Peru 1
Pisa 1
Quito 1
Ribeirão das Neves 1
Ridgefield 1
Sac City 1
Santa Elena 1
Santiago 1
Shanghai 1
Sharjah 1
Shenyang 1
Spilimbergo 1
Sydney 1
São Sebastião 1
Taipei 1
Talmassons 1
Tegucigalpa 1
Toyama 1
Tres Arroyos 1
Uberaba 1
Vadodara 1
Zhengzhou 1
İnegöl 1
Totale 294
Nome #
Selection of Natural Compounds with HMGA-Interfering Activities and Cancer Cell Cytotoxicity 108
Oral Administration of Cancer Vaccines: Challenges and Future Perspectives 89
Gut Microbiota-Based Immunotherapy: Engineered Escherichia coli Nissle 1917 for Oral Delivery of Glypican-1 in Pancreatic Cancer 79
Polymeric Nanoparticles for Oral Delivery of a Chimeric Protein as a Vaccination Approach for the Treatment of Glypican-1-expressing Pancreatic Ductal Adenocarcinoma 65
Totale 341
Categoria #
all - tutte 667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 667


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202412 0 0 0 0 0 0 0 7 0 2 2 1
2024/202533 0 3 1 1 3 6 0 2 2 4 5 6
2025/2026296 7 3 91 17 18 16 28 21 39 56 0 0
Totale 341